The present study was designed to assess the association of CCL22 and TGF-β1 expression in tumor cells with the status of Treg infiltration in invasive breast carcinoma, and in addition, to evaluate their prognostic significance for BC patients. This evidence concerns the gene CCL22 and neoplasm.